19 Hrs
Source:
اليوم السابع
_1777352142843_145525226.png&w=64&q=75){kind=small}
Source: اليوم السابع
19 Hrsاليوم السابع
Source: اليوم السابع
19 HrsReady to play
Ready to play
The Egyptian Drug Authority detected misleading advertisements for unregistered weight-loss products, including Retatrutide, Reta, Lily A-Lock, Slim Cut Shot, Exolime, Mesoline, Procut, and Uncut, as well as advertisements for Tirzepatide. It warned that products of unknown origin may contain undisclosed ingredients or doses. The Authority also stressed that Retatrutide is still undergoing clinical trials, while Tirzepatide is an active ingredient in a registered medicine—not the name of a separately registered product. The Authority said it had identified and addressed 539 advertising violations and filed 496 reports. It urged the public to buy medicines from licensed pharmacies, consult a doctor, and report suspicious advertisements via the hotline at 15301.
Notice: This Is an AI-Generated Summary
Comments (0)